Cite
Translocation (3;21)(q26;q22) in treatment-related acute leukemia secondary to acute promyelocytic leukemia
MLA
Nomura T, et al. “Translocation (3;21)(Q26;Q22) in Treatment-Related Acute Leukemia Secondary to Acute Promyelocytic Leukemia.” Cancer Genetics and Cytogenetics, vol. 74, June 1994, pp. 84–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62792a092b25caae8ad0b69ed6bcc2d0&authtype=sso&custid=ns315887.
APA
Nomura T, Motohiro Tuzuki, Ino T, Kojima H, Miyazaki H, Sobue R, Wakita M, & Masami Hirano. (1994). Translocation (3;21)(q26;q22) in treatment-related acute leukemia secondary to acute promyelocytic leukemia. Cancer Genetics and Cytogenetics, 74, 84–86.
Chicago
Nomura T, Motohiro Tuzuki, Ino T, Kojima H, Miyazaki H, Sobue R, Wakita M, and Masami Hirano. 1994. “Translocation (3;21)(Q26;Q22) in Treatment-Related Acute Leukemia Secondary to Acute Promyelocytic Leukemia.” Cancer Genetics and Cytogenetics 74 (June): 84–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62792a092b25caae8ad0b69ed6bcc2d0&authtype=sso&custid=ns315887.